A MULTICENTER, RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)

被引：0

作者：

Ahluwalia, Manmeet ^{[1
,2
]}

Ciesielski, Michael ^{[3
]}

Abad, Ajay ^{[4
]}

Reardon, David ^{[5
,6
]}

Ozair, Ahmad ^{[1
]}

Khosla, Atulya ^{[1
]}

Aiken, Robert ^{[7
]}

Barbaro, Marissa ^{[8
]}

Sinicrope, Kaylyn ^{[9
]}

Peereboom, David ^{[10
]}

Odia, Yazmin ^{[1
]}

Brenner, Andrew ^{[11
]}

Venur, Vyshak ^{[12
,13
]}

Belal, Ahmed ^{[4
]}

Qiu, Jingxin ^{[4
]}

Schilero, Cathy ^{[10
]}

Casucci, Danielle ^{[3
]}

Mechtler, Laszlo ^{[4
,14
]}

Fenstermaker, Robert ^{[4
]}

机构：

[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA

[2] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL USA

[3] Mimivax, Buffalo, NY USA

[4] Rosswell Park Comprehens Canc Ctr, Nokomis, NY USA

[5] Dana Farber Canc Inst, Stoughton, MA USA

[6] Harvard Med Sch, Dept Med, Boston, MA 02115 USA

[7] Atlantic Healthcare, Gerald J Glasser Brain Tumor Ctr, Summit, NJ USA

[8] NYU Langone Med Ctr, New York, NY USA

[9] Norton Brain Tumor Ctr, Loiusville, KY USA

[10] Cleveland Clin, Cleveland, OH USA

[11] UT Hlth San Antonio MD Anderson Canc Ctr, San Antonio, TX USA

[12] Fred Hutchinson Canc Ctr, Sunnyside, WA USA

[13] Univ Washington, Sch Med, Seattle, WA USA

[14] Jacobs Sch Med & Biomed Sci, Buffalo, NY USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae165.1080

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

RTID-04.

引用

页数：1

共 50 条

[31] JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma [J].

Wakabayashi, Toshihiko ;

Natsume, Atsushi ;

Mizusawa, Junki ;

Katayama, Hiroshi ;

Fukuda, Haruhiko ;

Sumi, Minako ;

Nishikawa, Ryo ;

Narita, Yoshitaka ;

Muragaki, Yoshihiro ;

Maruyama, Takashi ;

Ito, Tamio ;

Beppu, Takaaki ;

Nakamura, Hideo ;

Kayama, Takamasa ;

Sato, Shinya ;

Nagane, Motoo ;

Mishima, Kazuhiko ;

Nakasu, Yoko ;

Kurisu, Kaoru ;

Yamasaki, Fumiyuki ;

Sugiyama, Kazuhiko ;

Onishi, Takanori ;

Iwadate, Yasuo ;

Terasaki, Mizuhiko ;

Kobayashi, Hiroyuki ;

Matsumura, Akira ;

Ishikawa, Eiichi ;

Sasaki, Hikaru ;

Mukasa, Akitake ;

Matsuo, Takayuki ;

Hirano, Hirofumi ;

Kumabe, Toshihiro ;

Shinoura, Nobusada ;

Hashimoto, Naoya ;

Aoki, Tomokazu ;

Asai, Akio ;

Abe, Tatsuya ;

Yoshino, Atsuo ;

Arakawa, Yoshiki ;

Asano, Kenichiro ;

Yoshimoto, Koji ;

Shibui, Soichiro .

JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (03) :627-636

[32] JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma [J].

Toshihiko Wakabayashi ;

Atsushi Natsume ;

Junki Mizusawa ;

Hiroshi Katayama ;

Haruhiko Fukuda ;

Minako Sumi ;

Ryo Nishikawa ;

Yoshitaka Narita ;

Yoshihiro Muragaki ;

Takashi Maruyama ;

Tamio Ito ;

Takaaki Beppu ;

Hideo Nakamura ;

Takamasa Kayama ;

Shinya Sato ;

Motoo Nagane ;

Kazuhiko Mishima ;

Yoko Nakasu ;

Kaoru Kurisu ;

Fumiyuki Yamasaki ;

Kazuhiko Sugiyama ;

Takanori Onishi ;

Yasuo Iwadate ;

Mizuhiko Terasaki ;

Hiroyuki Kobayashi ;

Akira Matsumura ;

Eiichi Ishikawa ;

Hikaru Sasaki ;

Akitake Mukasa ;

Takayuki Matsuo ;

Hirofumi Hirano ;

Toshihiro Kumabe ;

Nobusada Shinoura ;

Naoya Hashimoto ;

Tomokazu Aoki ;

Akio Asai ;

Tatsuya Abe ;

Atsuo Yoshino ;

Yoshiki Arakawa ;

Kenichiro Asano ;

Koji Yoshimoto ;

Soichiro Shibui .

Journal of Neuro-Oncology, 2018, 138 :627-636

[33] Interim analysis of the randomized PATSGO trial evaluating the prolongation of adjuvant temozolomide in newly diagnosed glioblastoma patients. [J].

Baurain, J. ;

Boterberg, T. ;

Devriendt, D. ;

Hammouch, F. ;

Cosnard, G. ;

Whenham, N. ;

Clement, P. M. ;

Mitine, C. ;

Renard, L. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

[34] Phase 3 TRIDENT trial: Radiation and temozolomide plus /- Tumor Treating Fields in newly diagnosed glioblastoma [J].

Glas, M. .

STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) :S72-S72

[35] Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study. [J].

Lai, Shuzhen ;

Chen, Yuan Yuan Yuan ;

Li, Peijing ;

Jiang, Fagui ;

Liu, Xiaohui ;

Tao, Changjuan ;

Huang, Jing ;

Tang, Yiqiang ;

Liu, Zhigang ;

Shen, Guoping ;

Li, Chaoming ;

Xie, Tieming ;

Lu, Fangxiao ;

Liu, Guihong .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

[36] Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial [J].

Il Han Kim ;

Chul-Kee Park ;

Dae Seog Heo ;

Chae-Yong Kim ;

Chang Hun Rhee ;

Do-Hyun Nam ;

Seung Hoon Lee ;

Jung Ho Han ;

Se-Hoon Lee ;

Tae Min Kim ;

Dong-Wan Kim ;

Jeong Eun Kim ;

Sun Ha Paek ;

Dong Gyu Kim ;

In Ah Kim ;

Yu Jung Kim ;

Jee Hyun Kim ;

Byung-Joo Park ;

Hee-Won Jung .

Journal of Neuro-Oncology, 2011, 103 :595-602

[37] RADIOTHERAPY FOLLOWED BY ADJUVANT TEMOZOLOMIDE WITH OR WITHOUT NEOADJUVANT ACNU-CDDP CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMAS: A PROSPECTIVE RANDOMIZED CONTROLLED MULTICENTER PHASE III TRIAL [J].

Kim, Il Han ;

Park, Chul-Kee ;

Han, Jung Ho ;

Lee, Se-Hoon ;

Kim, Chae-Yong ;

Kim, Tae Min ;

Kim, Dong-Wan ;

Kim, Jeong Eun ;

Paek, Sun Ha ;

Kim, In Ah ;

Kim, Yu Jung ;

Kim, Jee Hyun ;

Nam, Do-Hyun ;

Rhee, Chang Hun ;

Lee, Seung Hoon ;

Park, Byung-Joo ;

Kim, Dons Gyu ;

Heo, Dae Seog ;

Jung, Hee-Won .

NEURO-ONCOLOGY, 2010, 12 :51-51

[38] Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial [J].

Kim, Il Han ;

Park, Chul-Kee ;

Heo, Dae Seog ;

Kim, Chae-Yong ;

Rhee, Chang Hun ;

Nam, Do-Hyun ;

Lee, Seung Hoon ;

Han, Jung Ho ;

Lee, Se-Hoon ;

Kim, Tae Min ;

Kim, Dong-Wan ;

Kim, Jeong Eun ;

Paek, Sun Ha ;

Kim, Dong Gyu ;

Kim, In Ah ;

Kim, Yu Jung ;

Kim, Jee Hyun ;

Park, Byung-Joo ;

Jung, Hee-Won .

JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) :595-602

[39] PHASE I STUDY OF BTK INHIBITOR IBRUTINIB WITH TEMOZOLOMIDE AND RADIATION IN NEWLY-DIAGNOSED GLIOBLASTOMA (EQUILIBRIUM): FINAL TRIAL REPORT [J].

Ahluwalia, Manmeet ;

Ozair, Ahmad ;

Khosla, Atulya ;

Patel, Neha ;

Elson, Paul ;

Murphy, Erin ;

Chao, Samuel ;

Suh, John ;

Stevens, Glen ;

Peereboom, David .

NEURO-ONCOLOGY, 2023, 25

[40] Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report [J].

Ahluwalia, Manmeet Singh ;

Ozair, Ahmad ;

Khosla, Atulya Aman ;

Patel, Neha ;

Elson, Paul ;

Murphy, Erin Sennett ;

Yu, Jennifer S. ;

Chao, Samuel T. ;

Suh, John H. ;

Stevens, Glen ;

Peereboom, David M. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

← 1 2 3 4 5 →